Abstract
Chronic inflammatory demyelinating polyneuropathy (CIDP) is an orphan disease of the peripheral nervous system. The clinical phenotypes of CIDP may influence the choice of primary pathogenetic therapy. In some cases, viral infection may be a trigger for the development of an immune-mediated process. The role of coronavirus infection (COVID-19) as a trigger of the clinical manifestation of CIDP, as well as the impact of COVID-19 on the disease course and response to pathogenetic therapy remains an unexplored issue. The paper presents a series of clinical cases CIDP with manifestations after COVID-19 infection and review of publications.
Keywords: Chronic inflammatory demyelinating polyneuropathy, coronavirus infection, COVID-19, electroneuromyography.
Keywords: Chronic inflammatory demyelinating polyneuropathy, coronavirus infection, COVID-19, electroneuromyography.
For citation:Kushnir Y.B., Bezvodinskikh A.I., Vladykina A.V., Totolyan N.A. Phenotypes of chronic inflammatory demyelinating polyneuropathies with manifestation after coronavirus infection COVID-19. Clinical review for general practice. 2024; 5 (5): 28–32 (In Russ.). DOI: 10.47407/kr2024.5.5.00402
All accepted articles publish licensed under a Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.
